Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicago
Biotech
Next-gen COVID shots need differentiation, pan-variant potential
Next-gen COVID shots from Sanofi/GSK, Gritstone, Valneva and others will need to be different from current shots, plus easy to scale up in production.
Annalee Armstrong
,
Kyle LaHucik
Jan 24, 2022 10:53am
GlaxoSmithKline, Medicago hit 75% efficacy against delta
Dec 7, 2021 7:00am
Medicago, GSK post data on plant-derived COVID-19 vaccine
May 18, 2021 5:21am
GSK kick-starts phase 3 Medicago-partnered COVID vaccine test
Mar 16, 2021 8:30am
GlaxoSmithKline pens COVID-19 vaccine pact with Medicago
Jul 7, 2020 8:55am